USE OF CATAPRES IN TREATMENT OF SEVERE HYPERTENSION

被引：23

作者：

RAFTOS, J

机构：

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1969年 / 2卷 / 14期

关键词：

D O I：

10.5694/j.1326-5377.1969.tb107345.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：684 / &

共 12 条

[1] GUANETHIDINE IN TREATMENT OF HYPERTENSION [J].

BAUER, GE ;

YOUNG, AA ;

WHYTE, HM ;

RAFTOS, J ;

JEREMY, D ;

GOLDRICK, RB ;

CROLL, FJT .

BRITISH MEDICAL JOURNAL, 1961, 2 (524) :410-&

[2] ANALYSIS OF CARDIOVASCULAR EFFECTS OF 2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (CATAPRES) [J].

CONSTANT.JW ;

MCSHANE, WK .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1968, 4 (02) :109-&

[3]

DAVIDOV M, 1967, CLIN PHARMACOL THER, V8, P810

[4]

GIFFORD RW, 1969, CATAPRES MANAGEMENT

[5]

KIRKENDALL WM, 1969, CATAPRES S LONDON

[6] INVESTIGATIONS INTO MECHANISM OF HYPOTENSIVE EFFECT OF 2-(2,6-DICHLORPHENYLAMINO)-2-IMIDAZOLINE-HCL [J].

KOBINGER, W ;

WALLAND, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1967, 2 (03) :155-&

[7]

Lewis R G, 1967, Med J Aust, V1, P339

[8]

NAYLER WG, 1968, J PHARMACOL EXP THER, V164, P45

[9]

NG DD, 1966, NZ MED J, V66, P864

[10]

RAFTOS J, 1964, Med J Aust, V1, P837

← 1 2 →